TaiwanJ Pharmaceuticals Co., Ltd.
6549.TWO
Price:
$8.01
Market Cap:
$641.78M
TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2011 and is based in Zhubei, Taiwan.
Industry
Biotechnology
IPO Date
2015-10-21
Stock Exchange
TWO
Ticker
6549.TWO
PE Ratio
[-25.03]
ROE
[-28.55%]
Current Ratio
[18.85]
Dividend Yield
[0%]
Enterprise Value
[610.53M]
Dividend History
The ROE as of December 2025 (TTM) for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) is -28.55%
According to TaiwanJ Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -28.55%. This represents a change of 78.08% compared to the average of -16.03% of the last 4 quarters.
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Historical ROE (quarterly & annually)
How has 6549.TWO ROE performed in the past?
The mean historical ROE of TaiwanJ Pharmaceuticals Co., Ltd. over the last ten years is -32.79%. The current -28.55% ROE has changed -12.93% with respect to the historical average. Over the past ten years (40 quarters), 6549.TWO's ROE was at its highest in in the June 2023 quarter at 14.26%. The ROE was at its lowest in in the December 2022 quarter at -115.81%.
Average
-32.79%
Median
-16.27%
Minimum
-129.14%
Maximum
-3.35%
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of TaiwanJ Pharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.60%
Maximum Annual ROE = -3.35%
Minimum Annual Increase = -93.00%
Minimum Annual ROE = -129.14%
| Year | ROE | Change |
|---|---|---|
| 2024 | -23.50% | 160.19% |
| 2023 | -9.03% | -93.00% |
| 2022 | -129.14% | 1.60% |
| 2021 | -7.60% | -68.52% |
| 2020 | -24.13% | 620.08% |
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Average ROE
How has 6549.TWO ROE performed in the past?
The current ROE of TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-53.89%
5-year avg
-38.68%
10-year avg
-32.79%
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) ROE vs. Peers
How is 6549.TWO’s ROE compared to its peers?
TaiwanJ Pharmaceuticals Co., Ltd.’s ROE is greater than Vectorite Biomedical Inc. (-5.93%), greater than Health & Life Co., Ltd. (-3.67%), less than BioLASCO Taiwan Co., Ltd. (11.19%), greater than Original BioMedicals Co., Ltd. (-37.93%), greater than Eusol Biotech Co.,Ltd. (-10.52%), less than Bioray Biotech Co., Ltd (7.09%), greater than SynCore Biotechnology Co.,Ltd (-18.31%), greater than Pharmigene, Inc. (-22.90%), greater than Sofiva Genomics Co.,Ltd. (-1.13%), greater than Andros Pharmaceuticals Co.,Ltd (-18.09%),
| Company | ROE | Market cap |
|---|---|---|
| -5.93% | $612.80M | |
| -3.67% | $530.97M | |
| 11.19% | $813.18M | |
| -37.93% | $938.89M | |
| -10.52% | $835.70M | |
| 7.09% | $606.50M | |
| -18.31% | $905.50M | |
| -22.90% | $524.90M | |
| -1.13% | $644.56M | |
| -18.09% | $1.22B |
Build a custom stock screener for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiwanJ Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like TaiwanJ Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is TaiwanJ Pharmaceuticals Co., Ltd.'s ROE?
How is the ROE calculated for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the highest ROE for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the 3-year average ROE for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the 5-year average ROE for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
How does the current ROE for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) compare to its historical average?